lal test in pharma Secrets
This was accompanied by revisions to the eu Pharmacopoeia in 2016, which involved recombinant variable C (rFC) as a substitute process, again issue to validation specifications. Having said that, this Modification specially attested that ‘the use of other reagents such as recombinant element C for a substitute to the amebocyte lysate eliminates t